Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with.
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with.
-Contineum is focused on leading the Neuroscience, Inflammation and Immunology field-
-Successful completion of Initial Public Offering with strong syndicate of existing and new investors-
.
SAN DIEGO (BUSINESS WIRE) Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today participation in the following upcoming investor conferences:Morgan Stanley 21st Annual Global Healthcare Conference, September 11-13, 2023, NY, NY:Pipeline management.